NeuroSense Therapeutics Ltd. Payments for Restructuring
NeuroSense Therapeutics Ltd. (NRSN) reported Payments for Restructuring of $25.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-03-31
| Period end | Payments for Restructuring 12 month |
|---|---|
| 2025-12-31 | $25.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $25.00M 20-F · filed 2025-04-07 |